Edwards Lifesciences Valuation

Edwards Lifesciences Corporation -- USA Stock  

USD 142.34  1.24  0.88%

Edwards Lifesciences shows prevailing Real Value of $129.19675 per share. The current price of the firm is $142.34. At this time the firm appears to be over valued. Macroaxis computes value of Edwards Lifesciences from reviewing the firm fundamentals such as Shares Outstanding of 210.02M, Profit Margin of 16.99% and Current Valuation of 29.28B as well as analyzing its technical indicators and Probability Of Bankruptcy. In general, we advise to go long with undervalued instruments and to sell out overvalued instruments since at some point assets prices and their ongoing real values will submerge.

Valuation Drivers Correlation

Selected Edwards Lifesciences Corporation Valuation Data Over Time

Net Income Per Employee    Enterprise Value    Invested Capital Average    
 Time Horizon     30 Days    Login   to change
Edwards Lifesciences Corporation is rated # 2 in price to sales category among related companies. It is rated # 4 in price to earning category among related companies reporting about  6.06  of Price to Earning per Price to Sales.
Over Valued
March 19, 2018
Market Value
Downside upside
Real Value
Target Price Odds
 Above  Below  
Upside upside
Edwards Lifesciences is not too risky asset. Calculation of real value of Edwards Lifesciences is based on 1 month time horizon. Increasing Edwards Lifesciences time horizon generally increases accuracy of value calculation and significantly improves predictive power of the methodology used.


Edwards Lifesciences Analyst Recommendations
Target PriceAdvice# of Analysts
Edwards Lifesciences Corporation current and past analyst recommendations published by number of research institutions as well as average analyst consensus
Edwards Lifesciences Analyst Advice  

Tax Efficiency

Edwards Lifesciences Tax Efficiency History

Tax Efficiency

Market Capitalization

Edwards Lifesciences Market Capitalization Analysis
Edwards Lifesciences Corporation is rated # 5 in market capitalization category among related companies. Market capitalization of Healthcare Products industry is currently estimated at about 244.17 Billion. Edwards Lifesciences retains roughly 29.61 Billion in market capitalization claiming about 12% of equities under Healthcare Products industry.
Capitalization  Workforce  Revenue  Valuation  Total debt


Edwards Lifesciences Revenue
Based on latest financial disclosure Edwards Lifesciences Corporation reported 3.44 B of revenue. This is 47.08% lower than that of the Healthcare sector, and significantly higher than that of Healthcare Products industry, The Revenue for all stocks is 65.06% higher than the company.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can includes product or services discounts, promotions, as well as early payments on invoices or services rendered in advance.